P0657 : Adding tenofovir to Pegylated Interferon enhances end of treatment HBsAg loss in HBeAg negative chronic hepatitis B patients

Autor: Marcellin, P., Martinot Peignoux, M., Moucari, R., Lapalus, M., Castelnau, C., Mouri, F., Pouteau, M., Giuliy, N., Boyer, N., Asselah, T.
Zdroj: In Journal of Hepatology April 2015 62 Supplement 2:S566-S567
Databáze: ScienceDirect